Identification of poor prognostic factors using circulating extracellular vesicles in durvalumab consolidation therapy for locally advanced non-small cell lung cancer. - Utsumi H; Yagishita S; Kawajiri K; Torasawa M; Kiritani A; Tamura K; Wakui H; Horinouchi H; Araya J; Fujita Y (Lung cancer (Amsterdam, Netherlands), 2025)